Document is current

Any future updates will be listed below

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD

Crossref DOI link: https://doi.org/10.1038/s41575-021-00445-1

Published Online: 2021-03-30

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark